Shareholder Notice

Invesco Markets III plc

Ground Floor, 2 Cumberland Place, Fenian Street, Dublin 2, Ireland

Telephone +353 1 439 8000 www.invesco.com

THIS DOCUMENT IS IMPORTANT AND REQUIRES YOUR IMMEDIATE ATTENTION

SHAREHOLDER NOTICE

This notice is sent to you as a Shareholder in the Fund, a sub-fund of Invesco Markets III plc (the "Company"). It is important and requires your immediate attention. If you are in any doubt as to the action you should take, seek advice from your stockbroker, bank manager, solicitor, accountant or independent financial adviser. Please note that this notice has not been reviewed by the Central Bank of Ireland (the "Central Bank").

If you have sold or transferred your shares in the Fund, then no action is required.

Unless otherwise defined herein, all capitalised terms used herein shall bear the same meaning as capitalised terms used in the latest prospectus of the Company (the "Prospectus"). A copy of the Prospectus is available at etf.invesco.com and on request during normal business hours from the Company or from the local representative of the Company in any jurisdiction in which the Fund is registered for public distribution, including from the German information agent Marcard, Stein & Co AG, Ballindamm 36, 20095 Hamburg, Germany and in Switzerland at BNP Paribas Securities Services, Paris, succursale de Zurich, Selnaustrasse 16, 8002 Zurich which is the Swiss representative and paying agent.

The Directors accept responsibility for the information contained in this Circular. To the best of the knowledge and belief of the Directors (who have taken all reasonable care to ensure that such is the case) the information contained in this Circular is in accordance with the facts and does not omit anything likely to affect the import of such information.

2 April 2026

RE:         Invesco RAFI Emerging Markets Fundamental Value UCITS ETF (ISIN: IE00B23D9570) (the 'Fund').

Dear Shareholder

This notice is to inform you that the following changes to the Fund took effect on 23 March 2026 following approval by Shareholders at the extraordinary general meeting held on 05 February 2026: 

As a result of the rebenchmarking and to better achieve the investment objective of the Fund, the Fund's strategy was changed from full replication to sampling with effect from 23 March 2026. The Prospectus has been updated to reflect these changes.